

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 7.05240803 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 5.57050586 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.57050586 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.57050586 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.57050586 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 5.57050586 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 5.57050586 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 5.38497199 |
| 9 | response to peptidoglycan (GO:0032494) | 4.51944848 |
| 10 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.49990557 |
| 11 | macrophage activation involved in immune response (GO:0002281) | 4.33077032 |
| 12 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 4.16885834 |
| 13 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.10894041 |
| 14 | response to host immune response (GO:0052572) | 4.08734028 |
| 15 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.08734028 |
| 16 | respiratory burst (GO:0045730) | 4.06644706 |
| 17 | negative regulation of interleukin-12 production (GO:0032695) | 4.03164644 |
| 18 | positive regulation of interferon-alpha production (GO:0032727) | 3.97714703 |
| 19 | platelet dense granule organization (GO:0060155) | 3.96687212 |
| 20 | microglial cell activation (GO:0001774) | 3.91377996 |
| 21 | immunoglobulin mediated immune response (GO:0016064) | 3.91312001 |
| 22 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.86846816 |
| 23 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.80228794 |
| 24 | regulation of interferon-alpha production (GO:0032647) | 3.78068641 |
| 25 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.68684519 |
| 26 | myeloid cell activation involved in immune response (GO:0002275) | 3.68201447 |
| 27 | response to host (GO:0075136) | 3.66072778 |
| 28 | response to host defenses (GO:0052200) | 3.66072778 |
| 29 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.66072778 |
| 30 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.52058144 |
| 31 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.50320529 |
| 32 | detection of other organism (GO:0098543) | 3.50216464 |
| 33 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.49794783 |
| 34 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.49794783 |
| 35 | neutrophil activation (GO:0042119) | 3.47346527 |
| 36 | detection of external biotic stimulus (GO:0098581) | 3.46427357 |
| 37 | positive regulation of B cell differentiation (GO:0045579) | 3.46236442 |
| 38 | regulation of chemokine biosynthetic process (GO:0045073) | 3.43711168 |
| 39 | granulocyte activation (GO:0036230) | 3.43171016 |
| 40 | negative regulation of interleukin-17 production (GO:0032700) | 3.42194678 |
| 41 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.40099000 |
| 42 | B cell mediated immunity (GO:0019724) | 3.39828332 |
| 43 | regulation of mast cell activation (GO:0033003) | 3.37066999 |
| 44 | macrophage activation (GO:0042116) | 3.33946010 |
| 45 | response to interferon-beta (GO:0035456) | 3.30322115 |
| 46 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.30198256 |
| 47 | defense response to protozoan (GO:0042832) | 3.28402844 |
| 48 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.27646071 |
| 49 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.25577552 |
| 50 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.22819250 |
| 51 | negative regulation of mast cell activation (GO:0033004) | 3.21573148 |
| 52 | actin nucleation (GO:0045010) | 3.19463772 |
| 53 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.18979194 |
| 54 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.17991808 |
| 55 | regulation of mast cell degranulation (GO:0043304) | 3.16188619 |
| 56 | positive regulation of antigen processing and presentation (GO:0002579) | 3.14638415 |
| 57 | detection of molecule of bacterial origin (GO:0032490) | 3.14276846 |
| 58 | positive regulation of macrophage differentiation (GO:0045651) | 3.12237955 |
| 59 | phagosome maturation (GO:0090382) | 3.11927091 |
| 60 | neutrophil mediated immunity (GO:0002446) | 3.11773333 |
| 61 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.11041204 |
| 62 | positive regulation of mast cell activation (GO:0033005) | 3.10301757 |
| 63 | negative regulation of interleukin-1 production (GO:0032692) | 3.07505222 |
| 64 | response to protozoan (GO:0001562) | 3.07400078 |
| 65 | response to interferon-alpha (GO:0035455) | 3.06139749 |
| 66 | mast cell activation (GO:0045576) | 3.05115623 |
| 67 | proteasome assembly (GO:0043248) | 3.04732664 |
| 68 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 3.04688722 |
| 69 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.03642251 |
| 70 | melanin biosynthetic process (GO:0042438) | 3.02533192 |
| 71 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.01065843 |
| 72 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.01021286 |
| 73 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.99430259 |
| 74 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.99179527 |
| 75 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.98993395 |
| 76 | type I interferon signaling pathway (GO:0060337) | 2.98440185 |
| 77 | cellular response to type I interferon (GO:0071357) | 2.98440185 |
| 78 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.98102815 |
| 79 | negative regulation of cell killing (GO:0031342) | 2.97146781 |
| 80 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.97146781 |
| 81 | phagocytosis, engulfment (GO:0006911) | 2.97118678 |
| 82 | detection of biotic stimulus (GO:0009595) | 2.96785567 |
| 83 | myeloid leukocyte activation (GO:0002274) | 2.95702344 |
| 84 | response to type I interferon (GO:0034340) | 2.95655661 |
| 85 | superoxide anion generation (GO:0042554) | 2.94482107 |
| 86 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.93340750 |
| 87 | regulation of B cell differentiation (GO:0045577) | 2.92180762 |
| 88 | cellular extravasation (GO:0045123) | 2.92145435 |
| 89 | myeloid dendritic cell activation (GO:0001773) | 2.91859102 |
| 90 | endosome to melanosome transport (GO:0035646) | 2.91031084 |
| 91 | endosome to pigment granule transport (GO:0043485) | 2.91031084 |
| 92 | positive regulation of interferon-beta production (GO:0032728) | 2.89416665 |
| 93 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.88838893 |
| 94 | response to lipoprotein particle (GO:0055094) | 2.88183091 |
| 95 | secondary metabolite biosynthetic process (GO:0044550) | 2.87576318 |
| 96 | cellular response to interferon-beta (GO:0035458) | 2.87553199 |
| 97 | membrane invagination (GO:0010324) | 2.87239964 |
| 98 | detection of bacterium (GO:0016045) | 2.84730020 |
| 99 | response to xenobiotic stimulus (GO:0009410) | 2.83976066 |
| 100 | angiogenesis involved in wound healing (GO:0060055) | 2.82999067 |
| 101 | leukocyte mediated cytotoxicity (GO:0001909) | 2.82863412 |
| 102 | cytokine secretion (GO:0050663) | 2.80470433 |
| 103 | leukocyte degranulation (GO:0043299) | 2.79873370 |
| 104 | phospholipid homeostasis (GO:0055091) | 2.79658172 |
| 105 | Rap protein signal transduction (GO:0032486) | 2.79223405 |
| 106 | regulation of mononuclear cell migration (GO:0071675) | 2.77031856 |
| 107 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.74960686 |
| 108 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.74380210 |
| 109 | positive regulation of mast cell degranulation (GO:0043306) | 2.74305465 |
| 110 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.74305465 |
| 111 | regulation of antigen processing and presentation (GO:0002577) | 2.74027871 |
| 112 | myeloid dendritic cell differentiation (GO:0043011) | 2.73264188 |
| 113 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.70849914 |
| 114 | interferon-gamma production (GO:0032609) | 2.70766004 |
| 115 | dendritic cell migration (GO:0036336) | 2.69234523 |
| 116 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.68122110 |
| 117 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.66392811 |
| 118 | definitive hemopoiesis (GO:0060216) | 2.65929809 |
| 119 | amino sugar catabolic process (GO:0046348) | 2.64859775 |
| 120 | oligosaccharide catabolic process (GO:0009313) | 2.64774095 |
| 121 | negative regulation of phagocytosis (GO:0050765) | 2.64550398 |
| 122 | neutrophil chemotaxis (GO:0030593) | 2.63667714 |
| 123 | histamine secretion (GO:0001821) | 2.63474786 |
| 124 | positive regulation of interleukin-6 production (GO:0032755) | 2.63455685 |
| 125 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.62483913 |
| 126 | leukocyte aggregation (GO:0070486) | 2.62019851 |
| 127 | dendritic cell differentiation (GO:0097028) | 2.61209761 |
| 128 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.59554533 |
| 129 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.59473442 |
| 130 | natural killer cell mediated immunity (GO:0002228) | 2.59473442 |
| 131 | negative regulation of viral genome replication (GO:0045071) | 2.59270029 |
| 132 | signal peptide processing (GO:0006465) | 2.58318541 |
| 133 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.57194113 |
| 134 | response to muramyl dipeptide (GO:0032495) | 2.56558686 |
| 135 | neutrophil migration (GO:1990266) | 2.56397512 |
| 136 | myeloid leukocyte mediated immunity (GO:0002444) | 2.56181335 |
| 137 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.56008544 |
| 138 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.55819623 |
| 139 | melanin metabolic process (GO:0006582) | 2.55466454 |
| 140 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.54872749 |
| 141 | keratan sulfate catabolic process (GO:0042340) | 2.54555911 |
| 142 | response to thyroid hormone (GO:0097066) | 2.51068912 |
| 143 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.49975284 |
| 144 | intracellular pH reduction (GO:0051452) | 2.49075051 |
| 145 | T-helper 1 type immune response (GO:0042088) | 2.48434051 |
| 146 | positive regulation of macrophage cytokine production (GO:0060907) | 2.47741070 |
| 147 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.47470482 |
| 148 | glycosphingolipid catabolic process (GO:0046479) | 2.43689652 |
| 149 | regulation of heat generation (GO:0031650) | 2.41143976 |
| 150 | regulation of podosome assembly (GO:0071801) | 2.38273094 |
| 151 | negative regulation of lipid storage (GO:0010888) | 2.37697341 |
| 152 | regulation of fever generation (GO:0031620) | 2.37535726 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.19601707 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.08375261 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.07890759 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 4.05143361 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.00672960 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.98147572 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.93031989 |
| 8 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.57541476 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.55426340 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 3.51924221 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.34813207 |
| 12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.28711455 |
| 13 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.26599409 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.90303214 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.81507694 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.80551698 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.72022429 |
| 18 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.51464609 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.49572453 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.47102024 |
| 21 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.35102706 |
| 22 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.28817405 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.26270781 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.21362908 |
| 25 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.17758547 |
| 26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.11737121 |
| 27 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.07986479 |
| 28 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.05348101 |
| 29 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.00242606 |
| 30 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98931745 |
| 31 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.94105189 |
| 32 | * MYB_26560356_Chip-Seq_TH2_Human | 1.90115377 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.87786484 |
| 34 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.82631791 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.82365436 |
| 36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82121624 |
| 37 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.77181082 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.76804946 |
| 39 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.74549987 |
| 40 | P300_19829295_ChIP-Seq_ESCs_Human | 1.74390278 |
| 41 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.72137569 |
| 42 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.70025486 |
| 43 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.69332017 |
| 44 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.55405482 |
| 45 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.54612254 |
| 46 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.53859039 |
| 47 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.52420767 |
| 48 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.50902086 |
| 49 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50547729 |
| 50 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.50475724 |
| 51 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.49284945 |
| 52 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.49023115 |
| 53 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.47063947 |
| 54 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.46590586 |
| 55 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.45418900 |
| 56 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40418646 |
| 57 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.39952460 |
| 58 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.39518454 |
| 59 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39038565 |
| 60 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.38490100 |
| 61 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.34153729 |
| 62 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.33321512 |
| 63 | MYB_26560356_Chip-Seq_TH1_Human | 1.33311319 |
| 64 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.31680546 |
| 65 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.31548447 |
| 66 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30828981 |
| 67 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.29435116 |
| 68 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29297814 |
| 69 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.27898165 |
| 70 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.27274337 |
| 71 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.26459426 |
| 72 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.25982171 |
| 73 | MAF_26560356_Chip-Seq_TH1_Human | 1.25597665 |
| 74 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24988302 |
| 75 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.23264570 |
| 76 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22784252 |
| 77 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.22075201 |
| 78 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.20987184 |
| 79 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.17493947 |
| 80 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.17325310 |
| 81 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.17253112 |
| 82 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.16162312 |
| 83 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.15128718 |
| 84 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.15072136 |
| 85 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.14850046 |
| 86 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.14742649 |
| 87 | EWS_26573619_Chip-Seq_HEK293_Human | 1.14000084 |
| 88 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.13266724 |
| 89 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.12473550 |
| 90 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.12347915 |
| 91 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.10743632 |
| 92 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10083630 |
| 93 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.09675166 |
| 94 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.09316698 |
| 95 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.08477568 |
| 96 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.08295224 |
| 97 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.07839449 |
| 98 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.06735882 |
| 99 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.06558636 |
| 100 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.06158251 |
| 101 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.05711953 |
| 102 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.05711953 |
| 103 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.05681876 |
| 104 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.04252575 |
| 105 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03567337 |
| 106 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.03466224 |
| 107 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.03323948 |
| 108 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.03323948 |
| 109 | VDR_22108803_ChIP-Seq_LS180_Human | 1.03265153 |
| 110 | TP53_16413492_ChIP-PET_HCT116_Human | 1.02743164 |
| 111 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02621513 |
| 112 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.02490418 |
| 113 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.01988001 |
| 114 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.01806795 |
| 115 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.01020049 |
| 116 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.00513019 |
| 117 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.00361713 |
| 118 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00126258 |
| 119 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.99695549 |
| 120 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.98887714 |
| 121 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.97881252 |
| 122 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.97373457 |
| 123 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97295415 |
| 124 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.95816073 |
| 125 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.95526747 |
| 126 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94809025 |
| 127 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.94729882 |
| 128 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.94164723 |
| 129 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.93372558 |
| 130 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.93339870 |
| 131 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.92993868 |
| 132 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.92656439 |
| 133 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.92307511 |
| 134 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.92304408 |
| 135 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.92138244 |
| 136 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91091902 |
| 137 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90304747 |
| 138 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.89682893 |
| 139 | CJUN_26792858_Chip-Seq_BT549_Human | 0.89189453 |
| 140 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.88892848 |
| 141 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88054248 |
| 142 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.87436479 |
| 143 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.86293100 |
| 144 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.84001308 |
| 145 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.84001308 |
| 146 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.82965411 |
| 147 | UTX_26944678_Chip-Seq_JUKART_Human | 0.81273169 |
| 148 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81148652 |
| 149 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.80128928 |
| 150 | GATA2_19941826_ChIP-Seq_K562_Human | 0.75966481 |
| 151 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.75345193 |
| 152 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.74715511 |
| 153 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.74562825 |
| 154 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.72341223 |
| 155 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.71122759 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.11704025 |
| 2 | MP0003724_increased_susceptibility_to | 3.43409831 |
| 3 | MP0009785_altered_susceptibility_to | 3.31885942 |
| 4 | MP0003436_decreased_susceptibility_to | 3.27253642 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.24704674 |
| 6 | MP0005058_abnormal_lysosome_morphology | 3.19485372 |
| 7 | MP0002419_abnormal_innate_immunity | 3.02753593 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.83814333 |
| 9 | MP0005464_abnormal_platelet_physiology | 2.60067779 |
| 10 | MP0005025_abnormal_response_to | 2.59489483 |
| 11 | MP0006082_CNS_inflammation | 2.46762398 |
| 12 | MP0003303_peritoneal_inflammation | 2.44621705 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.38810120 |
| 14 | MP0005671_abnormal_response_to | 2.37375897 |
| 15 | MP0005408_hypopigmentation | 2.32952030 |
| 16 | MP0003172_abnormal_lysosome_physiology | 2.27888335 |
| 17 | MP0004510_myositis | 2.25155173 |
| 18 | MP0002723_abnormal_immune_serum | 2.17570623 |
| 19 | MP0005248_abnormal_Harderian_gland | 2.17291710 |
| 20 | MP0001819_abnormal_immune_cell | 2.12564402 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.11405990 |
| 22 | MP0003806_abnormal_nucleotide_metabolis | 2.07818370 |
| 23 | MP0005387_immune_system_phenotype | 2.05401162 |
| 24 | MP0001790_abnormal_immune_system | 2.05401162 |
| 25 | MP0005075_abnormal_melanosome_morpholog | 2.04976898 |
| 26 | MP0001800_abnormal_humoral_immune | 2.03055566 |
| 27 | MP0006054_spinal_hemorrhage | 1.99917412 |
| 28 | MP0000343_altered_response_to | 1.99847361 |
| 29 | MP0003195_calcinosis | 1.99372519 |
| 30 | MP0003136_yellow_coat_color | 1.97125921 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.97049171 |
| 32 | MP0000685_abnormal_immune_system | 1.94424951 |
| 33 | MP0005397_hematopoietic_system_phenotyp | 1.84745387 |
| 34 | MP0001545_abnormal_hematopoietic_system | 1.84745387 |
| 35 | MP0001853_heart_inflammation | 1.80672048 |
| 36 | MP0003183_abnormal_peptide_metabolism | 1.77568631 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.74350829 |
| 38 | MP0000372_irregular_coat_pigmentation | 1.73979871 |
| 39 | MP0002405_respiratory_system_inflammati | 1.68991495 |
| 40 | MP0005167_abnormal_blood-brain_barrier | 1.66547808 |
| 41 | MP0005174_abnormal_tail_pigmentation | 1.63466043 |
| 42 | MP0000569_abnormal_digit_pigmentation | 1.60795649 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.60712974 |
| 44 | MP0002006_tumorigenesis | 1.59207376 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.58259631 |
| 46 | MP0003300_gastrointestinal_ulcer | 1.57083376 |
| 47 | MP0002166_altered_tumor_susceptibility | 1.54252718 |
| 48 | MP0002398_abnormal_bone_marrow | 1.52661582 |
| 49 | MP0009333_abnormal_splenocyte_physiolog | 1.51994941 |
| 50 | MP0009764_decreased_sensitivity_to | 1.51965271 |
| 51 | MP0000716_abnormal_immune_system | 1.51398413 |
| 52 | MP0004808_abnormal_hematopoietic_stem | 1.51220443 |
| 53 | MP0000015_abnormal_ear_pigmentation | 1.46426194 |
| 54 | MP0005310_abnormal_salivary_gland | 1.44394133 |
| 55 | MP0002396_abnormal_hematopoietic_system | 1.44131945 |
| 56 | MP0002090_abnormal_vision | 1.42780932 |
| 57 | MP0009840_abnormal_foam_cell | 1.42289854 |
| 58 | MP0003448_altered_tumor_morphology | 1.41403941 |
| 59 | MP0004381_abnormal_hair_follicle | 1.40781879 |
| 60 | MP0008469_abnormal_protein_level | 1.40459328 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.39766607 |
| 62 | MP0003075_altered_response_to | 1.38505998 |
| 63 | MP0004947_skin_inflammation | 1.38293563 |
| 64 | MP0003191_abnormal_cellular_cholesterol | 1.37852706 |
| 65 | MP0009278_abnormal_bone_marrow | 1.36695885 |
| 66 | MP0001324_abnormal_eye_pigmentation | 1.36525649 |
| 67 | MP0000689_abnormal_spleen_morphology | 1.34958173 |
| 68 | MP0002132_abnormal_respiratory_system | 1.34645425 |
| 69 | MP0000858_altered_metastatic_potential | 1.33189217 |
| 70 | MP0001986_abnormal_taste_sensitivity | 1.32173226 |
| 71 | MP0002933_joint_inflammation | 1.29510903 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 1.29478940 |
| 73 | MP0005164_abnormal_response_to | 1.29425302 |
| 74 | MP0002429_abnormal_blood_cell | 1.28851777 |
| 75 | MP0005166_decreased_susceptibility_to | 1.27229620 |
| 76 | MP0002102_abnormal_ear_morphology | 1.27010858 |
| 77 | MP0010386_abnormal_urinary_bladder | 1.25276459 |
| 78 | MP0002722_abnormal_immune_system | 1.16231602 |
| 79 | MP0005171_absent_coat_pigmentation | 1.13826797 |
| 80 | MP0001879_abnormal_lymphatic_vessel | 1.13101104 |
| 81 | MP0003221_abnormal_cardiomyocyte_apopto | 1.12604511 |
| 82 | MP0004782_abnormal_surfactant_physiolog | 1.12601151 |
| 83 | MP0003828_pulmonary_edema | 1.11049900 |
| 84 | MP0004147_increased_porphyrin_level | 1.08933835 |
| 85 | MP0004883_abnormal_blood_vessel | 1.05284118 |
| 86 | MP0003279_aneurysm | 1.03700765 |
| 87 | MP0005257_abnormal_intraocular_pressure | 1.03229773 |
| 88 | MP0001958_emphysema | 1.03150267 |
| 89 | MP0002095_abnormal_skin_pigmentation | 1.02673153 |
| 90 | MP0003011_delayed_dark_adaptation | 1.01297587 |
| 91 | MP0000249_abnormal_blood_vessel | 1.00701969 |
| 92 | MP0008260_abnormal_autophagy | 0.99789694 |
| 93 | MP0004484_altered_response_of | 0.99430204 |
| 94 | MP0002877_abnormal_melanocyte_morpholog | 0.98663511 |
| 95 | MP0002332_abnormal_exercise_endurance | 0.97998159 |
| 96 | MP0005390_skeleton_phenotype | 0.96792034 |
| 97 | MP0003866_abnormal_defecation | 0.95812287 |
| 98 | MP0008004_abnormal_stomach_pH | 0.95468364 |
| 99 | MP0000604_amyloidosis | 0.95333638 |
| 100 | MP0005367_renal/urinary_system_phenotyp | 0.95027701 |
| 101 | MP0000516_abnormal_urinary_system | 0.95027701 |
| 102 | MP0000490_abnormal_crypts_of | 0.94496665 |
| 103 | MP0001873_stomach_inflammation | 0.94227082 |
| 104 | MP0000681_abnormal_thyroid_gland | 0.91556371 |
| 105 | MP0003186_abnormal_redox_activity | 0.88400007 |
| 106 | MP0005253_abnormal_eye_physiology | 0.85879158 |
| 107 | MP0003795_abnormal_bone_structure | 0.84505816 |
| 108 | MP0001851_eye_inflammation | 0.82975624 |
| 109 | MP0001663_abnormal_digestive_system | 0.80240795 |
| 110 | MP0000920_abnormal_myelination | 0.80228979 |
| 111 | MP0003763_abnormal_thymus_physiology | 0.79458491 |
| 112 | MP0000371_diluted_coat_color | 0.79457652 |
| 113 | MP0005647_abnormal_sex_gland | 0.79415506 |
| 114 | MP0001764_abnormal_homeostasis | 0.78996114 |
| 115 | MP0003690_abnormal_glial_cell | 0.78292655 |
| 116 | MP0002277_abnormal_respiratory_mucosa | 0.77632614 |
| 117 | MP0009763_increased_sensitivity_to | 0.75696398 |
| 118 | MP0002735_abnormal_chemical_nociception | 0.75448928 |
| 119 | MP0003943_abnormal_hepatobiliary_system | 0.74836877 |
| 120 | MP0002075_abnormal_coat/hair_pigmentati | 0.73947425 |
| 121 | MP0003890_abnormal_embryonic-extraembry | 0.73538530 |
| 122 | MP0000767_abnormal_smooth_muscle | 0.72469807 |
| 123 | MP0001186_pigmentation_phenotype | 0.71899178 |
| 124 | MP0002254_reproductive_system_inflammat | 0.71889438 |
| 125 | MP0009697_abnormal_copulation | 0.70465611 |
| 126 | MP0002138_abnormal_hepatobiliary_system | 0.70022510 |
| 127 | MP0001915_intracranial_hemorrhage | 0.68723907 |
| 128 | MP0003566_abnormal_cell_adhesion | 0.68423953 |
| 129 | MP0005165_increased_susceptibility_to | 0.68323129 |
| 130 | MP0002139_abnormal_hepatobiliary_system | 0.66529748 |
| 131 | MP0005376_homeostasis/metabolism_phenot | 0.62417796 |
| 132 | MP0009765_abnormal_xenobiotic_induced | 0.56982547 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.53415584 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.62323017 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.55724160 |
| 4 | Increased cerebral lipofuscin (HP:0011813) | 5.18382303 |
| 5 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.10840552 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 5.03458504 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.65460845 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.24872689 |
| 9 | Myositis (HP:0100614) | 4.17276089 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.84165371 |
| 11 | Dysostosis multiplex (HP:0000943) | 3.79264187 |
| 12 | Interstitial pulmonary disease (HP:0006530) | 3.54896165 |
| 13 | Orchitis (HP:0100796) | 3.53451961 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 3.45466078 |
| 15 | Petechiae (HP:0000967) | 3.43765466 |
| 16 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.33819587 |
| 17 | Optic neuritis (HP:0100653) | 3.29271002 |
| 18 | Retrobulbar optic neuritis (HP:0100654) | 3.29271002 |
| 19 | Albinism (HP:0001022) | 3.25890209 |
| 20 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.25122922 |
| 21 | Mucopolysacchariduria (HP:0008155) | 3.25122922 |
| 22 | Recurrent skin infections (HP:0001581) | 3.24838968 |
| 23 | Systemic lupus erythematosus (HP:0002725) | 3.18780330 |
| 24 | Gingivitis (HP:0000230) | 3.18279015 |
| 25 | Chronic obstructive pulmonary disease (HP:0006510) | 3.16716310 |
| 26 | Obstructive lung disease (HP:0006536) | 3.16716310 |
| 27 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.13849994 |
| 28 | Stomatitis (HP:0010280) | 2.97396345 |
| 29 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.96430307 |
| 30 | Hypoplasia of the fovea (HP:0007750) | 2.96430307 |
| 31 | Abnormality of glycolipid metabolism (HP:0010969) | 2.96334940 |
| 32 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.96334940 |
| 33 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.96334940 |
| 34 | Hypothermia (HP:0002045) | 2.95460471 |
| 35 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.94241894 |
| 36 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.94241894 |
| 37 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.94241894 |
| 38 | Keratoconjunctivitis (HP:0001096) | 2.88400106 |
| 39 | Mutism (HP:0002300) | 2.84392729 |
| 40 | Recurrent fungal infections (HP:0002841) | 2.84120104 |
| 41 | Amyloidosis (HP:0011034) | 2.82705569 |
| 42 | Myocardial infarction (HP:0001658) | 2.81824908 |
| 43 | Cellulitis (HP:0100658) | 2.79943824 |
| 44 | IgM deficiency (HP:0002850) | 2.79421652 |
| 45 | Disinhibition (HP:0000734) | 2.73981679 |
| 46 | Autoimmune thrombocytopenia (HP:0001973) | 2.73893656 |
| 47 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.70632103 |
| 48 | Chronic otitis media (HP:0000389) | 2.64973188 |
| 49 | Nuclear cataract (HP:0100018) | 2.64062544 |
| 50 | Agnosia (HP:0010524) | 2.62130575 |
| 51 | Vasculitis (HP:0002633) | 2.59457421 |
| 52 | Abnormality of the fovea (HP:0000493) | 2.58930040 |
| 53 | Prolonged bleeding time (HP:0003010) | 2.57429320 |
| 54 | Vertebral compression fractures (HP:0002953) | 2.56150698 |
| 55 | Osteomyelitis (HP:0002754) | 2.55313374 |
| 56 | Axonal loss (HP:0003447) | 2.48590160 |
| 57 | Spontaneous hematomas (HP:0007420) | 2.47619131 |
| 58 | Ocular albinism (HP:0001107) | 2.46511587 |
| 59 | Hematochezia (HP:0002573) | 2.46455127 |
| 60 | T lymphocytopenia (HP:0005403) | 2.45193393 |
| 61 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.43871178 |
| 62 | Periodontitis (HP:0000704) | 2.39465780 |
| 63 | Prostate neoplasm (HP:0100787) | 2.39446784 |
| 64 | Abnormality of T cell number (HP:0011839) | 2.38436334 |
| 65 | Increased CSF protein (HP:0002922) | 2.38395686 |
| 66 | Basal ganglia calcification (HP:0002135) | 2.38296927 |
| 67 | Thrombocytosis (HP:0001894) | 2.37999303 |
| 68 | Pustule (HP:0200039) | 2.36912246 |
| 69 | Recurrent viral infections (HP:0004429) | 2.32556369 |
| 70 | Meningitis (HP:0001287) | 2.30510023 |
| 71 | Generalized hypopigmentation (HP:0007513) | 2.30398603 |
| 72 | Beaking of vertebral bodies (HP:0004568) | 2.30256404 |
| 73 | Loss of speech (HP:0002371) | 2.28067854 |
| 74 | Abnormality of the lumbar spine (HP:0100712) | 2.27931870 |
| 75 | Abnormal platelet function (HP:0011869) | 2.27391920 |
| 76 | Impaired platelet aggregation (HP:0003540) | 2.27391920 |
| 77 | J-shaped sella turcica (HP:0002680) | 2.26541501 |
| 78 | Inappropriate behavior (HP:0000719) | 2.26367309 |
| 79 | Glomerulonephritis (HP:0000099) | 2.25599405 |
| 80 | Purpura (HP:0000979) | 2.24868187 |
| 81 | Iris hypopigmentation (HP:0007730) | 2.22727866 |
| 82 | Polyneuropathy (HP:0001271) | 2.22013695 |
| 83 | Recurrent pneumonia (HP:0006532) | 2.21507903 |
| 84 | Cutaneous melanoma (HP:0012056) | 2.19778174 |
| 85 | Arterial thrombosis (HP:0004420) | 2.18804922 |
| 86 | Keratitis (HP:0000491) | 2.18207437 |
| 87 | Gingival bleeding (HP:0000225) | 2.17406320 |
| 88 | Epistaxis (HP:0000421) | 2.16364820 |
| 89 | Congenital sensorineural hearing impairment (HP:0008527) | 2.15483998 |
| 90 | Episodic fever (HP:0001954) | 2.14998300 |
| 91 | Pulmonary infiltrates (HP:0002113) | 2.13758723 |
| 92 | Abnormal auditory evoked potentials (HP:0006958) | 2.13178635 |
| 93 | Hepatosplenomegaly (HP:0001433) | 2.12795616 |
| 94 | Facial diplegia (HP:0001349) | 2.11465877 |
| 95 | Hypochromic microcytic anemia (HP:0004840) | 2.09711737 |
| 96 | Encephalitis (HP:0002383) | 2.08633166 |
| 97 | Amyotrophic lateral sclerosis (HP:0007354) | 2.08606394 |
| 98 | Nausea (HP:0002018) | 2.07675107 |
| 99 | Eosinophilia (HP:0001880) | 2.07395610 |
| 100 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.04143646 |
| 101 | Subacute progressive viral hepatitis (HP:0006572) | 2.04136207 |
| 102 | Dyschromatopsia (HP:0007641) | 2.01587135 |
| 103 | Keratoconjunctivitis sicca (HP:0001097) | 1.98917074 |
| 104 | Progressive neurologic deterioration (HP:0002344) | 1.98670553 |
| 105 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.97864248 |
| 106 | Abnormality of the prostate (HP:0008775) | 1.97169941 |
| 107 | Neoplasm of head and neck (HP:0012288) | 1.94538642 |
| 108 | Esophageal neoplasm (HP:0100751) | 1.94538642 |
| 109 | Hemoptysis (HP:0002105) | 1.94114461 |
| 110 | Reduced antithrombin III activity (HP:0001976) | 1.93336027 |
| 111 | Hypergammaglobulinemia (HP:0010702) | 1.93042792 |
| 112 | Tetraparesis (HP:0002273) | 1.91900127 |
| 113 | Urticaria (HP:0001025) | 1.91408337 |
| 114 | Hypokinesia (HP:0002375) | 1.90970978 |
| 115 | Choroideremia (HP:0001139) | 1.88858236 |
| 116 | Blue irides (HP:0000635) | 1.88472929 |
| 117 | Patchy hypopigmentation of hair (HP:0011365) | 1.88328843 |
| 118 | White forelock (HP:0002211) | 1.86678500 |
| 119 | Recurrent lower respiratory tract infections (HP:0002783) | 1.86248299 |
| 120 | Recurrent bronchitis (HP:0002837) | 1.84371864 |
| 121 | Thick nail (HP:0001805) | 1.84139530 |
| 122 | Spondylolisthesis (HP:0003302) | 1.83519838 |
| 123 | Parakeratosis (HP:0001036) | 1.83507953 |
| 124 | Pathologic fracture (HP:0002756) | 1.82455479 |
| 125 | Thyroiditis (HP:0100646) | 1.80744445 |
| 126 | Poor head control (HP:0002421) | 1.80738356 |
| 127 | Abnormality of eosinophils (HP:0001879) | 1.80389113 |
| 128 | Degeneration of anterior horn cells (HP:0002398) | 1.79783156 |
| 129 | Abnormality of the anterior horn cell (HP:0006802) | 1.79783156 |
| 130 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.78574964 |
| 131 | Recurrent cutaneous fungal infections (HP:0011370) | 1.78574964 |
| 132 | Metaphyseal dysplasia (HP:0100255) | 1.78408946 |
| 133 | Abnormality of the nasal mucosa (HP:0000433) | 1.78143936 |
| 134 | Thoracic kyphosis (HP:0002942) | 1.77145397 |
| 135 | Abnormal hair whorl (HP:0010721) | 1.76253500 |
| 136 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.75593569 |
| 137 | Osteolytic defects of the hand bones (HP:0009699) | 1.75593569 |
| 138 | Leukocytosis (HP:0001974) | 1.75493240 |
| 139 | Cerebral hemorrhage (HP:0001342) | 1.75472982 |
| 140 | Anorexia (HP:0002039) | 1.74175742 |
| 141 | Cervical subluxation (HP:0003308) | 1.73988056 |
| 142 | Intrahepatic cholestasis (HP:0001406) | 1.73957244 |
| 143 | Abnormality of T cell physiology (HP:0011840) | 1.73408500 |
| 144 | Sepsis (HP:0100806) | 1.73304500 |
| 145 | Increased IgM level (HP:0003496) | 1.72349048 |
| 146 | Thoracolumbar scoliosis (HP:0002944) | 1.72130067 |
| 147 | Gangrene (HP:0100758) | 1.68950761 |
| 148 | Chest pain (HP:0100749) | 1.63047536 |
| 149 | Pulmonary embolism (HP:0002204) | 1.62258350 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28 | 4.03612309 |
| 2 | RIPK4 | 3.22085316 |
| 3 | MAP3K12 | 3.19844793 |
| 4 | BLK | 3.15620456 |
| 5 | KIT | 2.92748020 |
| 6 | TGFBR2 | 2.68867810 |
| 7 | MAP3K14 | 2.61370791 |
| 8 | TBK1 | 2.59757478 |
| 9 | IRAK4 | 2.37381828 |
| 10 | PDK2 | 2.34291110 |
| 11 | WNK3 | 2.32272342 |
| 12 | BCR | 2.32147259 |
| 13 | TXK | 2.26455147 |
| 14 | JAK3 | 2.22969621 |
| 15 | PIM2 | 2.18664645 |
| 16 | CAMKK2 | 2.14975513 |
| 17 | MAP4K1 | 2.12090053 |
| 18 | NME2 | 2.04026026 |
| 19 | TEC | 2.03654111 |
| 20 | ZAP70 | 1.96164647 |
| 21 | BTK | 1.90406039 |
| 22 | MATK | 1.82837582 |
| 23 | NEK9 | 1.81827325 |
| 24 | SYK | 1.80445316 |
| 25 | TYK2 | 1.77158057 |
| 26 | MST1R | 1.76814234 |
| 27 | IKBKE | 1.74436161 |
| 28 | FGR | 1.72185715 |
| 29 | TGFBR1 | 1.65163984 |
| 30 | MST4 | 1.62696561 |
| 31 | KDR | 1.51524383 |
| 32 | IKBKB | 1.46946232 |
| 33 | FER | 1.46070427 |
| 34 | WEE1 | 1.45395895 |
| 35 | TNIK | 1.39239219 |
| 36 | MAP2K3 | 1.38509354 |
| 37 | SCYL2 | 1.37768835 |
| 38 | IRAK3 | 1.36819987 |
| 39 | SIK3 | 1.36550731 |
| 40 | CSF1R | 1.34081789 |
| 41 | LYN | 1.33486753 |
| 42 | GRK7 | 1.31782799 |
| 43 | TIE1 | 1.31092089 |
| 44 | MAP4K2 | 1.29294904 |
| 45 | KSR1 | 1.29163916 |
| 46 | FES | 1.23749517 |
| 47 | MAPKAPK5 | 1.23471673 |
| 48 | ERBB3 | 1.22158604 |
| 49 | JAK1 | 1.18115409 |
| 50 | BMPR1B | 1.16997539 |
| 51 | LCK | 1.07731786 |
| 52 | IRAK2 | 1.05995245 |
| 53 | HCK | 1.04870284 |
| 54 | PBK | 1.04704514 |
| 55 | EPHA3 | 1.04331239 |
| 56 | NUAK1 | 1.03510341 |
| 57 | ERN1 | 1.03184563 |
| 58 | ACVR1B | 1.01730732 |
| 59 | MAP3K3 | 0.95988616 |
| 60 | PAK3 | 0.89663215 |
| 61 | MARK3 | 0.89369573 |
| 62 | PRKG2 | 0.89307039 |
| 63 | ADRBK2 | 0.89303400 |
| 64 | FGFR3 | 0.86579722 |
| 65 | TAOK3 | 0.86421562 |
| 66 | JAK2 | 0.84182337 |
| 67 | ITK | 0.82813688 |
| 68 | FLT3 | 0.82319703 |
| 69 | LRRK2 | 0.82149345 |
| 70 | MYLK | 0.81665991 |
| 71 | CSNK1G2 | 0.80823059 |
| 72 | CHUK | 0.79937654 |
| 73 | TRPM7 | 0.78394804 |
| 74 | PIM1 | 0.77383482 |
| 75 | MKNK2 | 0.77245252 |
| 76 | MAP3K11 | 0.76542408 |
| 77 | PRKCD | 0.75593724 |
| 78 | YES1 | 0.75204014 |
| 79 | BMPR2 | 0.74266235 |
| 80 | MKNK1 | 0.73644037 |
| 81 | MAP3K13 | 0.73478063 |
| 82 | PTK2B | 0.72571866 |
| 83 | CSK | 0.72413194 |
| 84 | DDR2 | 0.72187956 |
| 85 | ARAF | 0.70320552 |
| 86 | NEK1 | 0.69845544 |
| 87 | FRK | 0.66223794 |
| 88 | EIF2AK1 | 0.65885507 |
| 89 | TESK1 | 0.65430960 |
| 90 | STK16 | 0.64451781 |
| 91 | EPHB1 | 0.63896466 |
| 92 | MAP3K1 | 0.63357286 |
| 93 | DYRK3 | 0.62261862 |
| 94 | CSNK1G3 | 0.61067605 |
| 95 | CSNK1G1 | 0.60219540 |
| 96 | CDK6 | 0.58964777 |
| 97 | PLK3 | 0.58487924 |
| 98 | MAPK13 | 0.58251138 |
| 99 | ERBB4 | 0.58198600 |
| 100 | TNK2 | 0.57824376 |
| 101 | PINK1 | 0.57612856 |
| 102 | TAOK1 | 0.57318372 |
| 103 | MAP3K2 | 0.56696977 |
| 104 | CSNK1A1L | 0.56587587 |
| 105 | DAPK1 | 0.55718845 |
| 106 | STK3 | 0.54082128 |
| 107 | ROCK2 | 0.53032904 |
| 108 | RPS6KA4 | 0.51757229 |
| 109 | STK10 | 0.51563801 |
| 110 | CAMKK1 | 0.50740515 |
| 111 | ABL2 | 0.50155261 |
| 112 | BRSK2 | 0.49966966 |
| 113 | PDK1 | 0.49509571 |
| 114 | MAPKAPK2 | 0.48832822 |
| 115 | RPS6KA2 | 0.48220228 |
| 116 | LMTK2 | 0.46546814 |
| 117 | PRKCE | 0.45952240 |
| 118 | PAK4 | 0.45463162 |
| 119 | IGF1R | 0.44916401 |
| 120 | RPS6KA6 | 0.44082237 |
| 121 | CLK1 | 0.43452134 |
| 122 | EIF2AK3 | 0.42936570 |
| 123 | PIK3CG | 0.41890566 |
| 124 | MOS | 0.40840124 |
| 125 | EGFR | 0.40758739 |
| 126 | OXSR1 | 0.40636297 |
| 127 | ABL1 | 0.40615133 |
| 128 | NLK | 0.40337311 |
| 129 | PLK2 | 0.39416019 |
| 130 | ROCK1 | 0.38519651 |
| 131 | RAF1 | 0.38212877 |
| 132 | GRK5 | 0.37696921 |
| 133 | NEK6 | 0.37233207 |
| 134 | CDK8 | 0.36673004 |
| 135 | RPS6KC1 | 0.36041469 |
| 136 | RPS6KL1 | 0.36041469 |
| 137 | MAPK4 | 0.34901939 |
| 138 | IRAK1 | 0.34646199 |
| 139 | MAP3K5 | 0.34288881 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.90608414 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 2.45953781 |
| 3 | Phagosome_Homo sapiens_hsa04145 | 2.40119697 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.34909766 |
| 5 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.32065309 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.21855119 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.20361945 |
| 8 | Legionellosis_Homo sapiens_hsa05134 | 2.18999991 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 2.18050354 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.15156136 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 2.04604508 |
| 12 | Malaria_Homo sapiens_hsa05144 | 2.02627248 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.95325607 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.86653903 |
| 15 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.82031399 |
| 16 | Salmonella infection_Homo sapiens_hsa05132 | 1.79132976 |
| 17 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.75751943 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.73582427 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.71708243 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.71013991 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.70634615 |
| 22 | Shigellosis_Homo sapiens_hsa05131 | 1.70358904 |
| 23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.70154985 |
| 24 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.69637395 |
| 25 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.65440553 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.58440127 |
| 27 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.55973058 |
| 28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.53362047 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.52138987 |
| 30 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.51777118 |
| 31 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.49783126 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.49394853 |
| 33 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.48563193 |
| 34 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.40520565 |
| 35 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.39332654 |
| 36 | Allograft rejection_Homo sapiens_hsa05330 | 1.38573418 |
| 37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.38060781 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.33028338 |
| 39 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.32734252 |
| 40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.31889286 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30082347 |
| 42 | Influenza A_Homo sapiens_hsa05164 | 1.29408218 |
| 43 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.27977784 |
| 44 | Asthma_Homo sapiens_hsa05310 | 1.27468852 |
| 45 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.24293306 |
| 46 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.23457729 |
| 47 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.18693702 |
| 48 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.17189882 |
| 49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.13358105 |
| 50 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.13183437 |
| 51 | Apoptosis_Homo sapiens_hsa04210 | 1.13032919 |
| 52 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.11746731 |
| 53 | Hepatitis B_Homo sapiens_hsa05161 | 1.11575872 |
| 54 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.09628805 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 1.08971391 |
| 56 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.08526310 |
| 57 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.08392320 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.07596142 |
| 59 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.07577350 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.07159735 |
| 61 | Protein export_Homo sapiens_hsa03060 | 1.05080909 |
| 62 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.03951209 |
| 63 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.96390469 |
| 64 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.93626935 |
| 65 | Proteasome_Homo sapiens_hsa03050 | 0.93552401 |
| 66 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.92324712 |
| 67 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.90771267 |
| 68 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.88122706 |
| 69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.87411327 |
| 70 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.84261006 |
| 71 | Hepatitis C_Homo sapiens_hsa05160 | 0.82759101 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.80568871 |
| 73 | Viral myocarditis_Homo sapiens_hsa05416 | 0.75951814 |
| 74 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.75699084 |
| 75 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.74063129 |
| 76 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.70950729 |
| 77 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.69843789 |
| 78 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.67355917 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66670961 |
| 80 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.65912359 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65866020 |
| 82 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.65846206 |
| 83 | Peroxisome_Homo sapiens_hsa04146 | 0.65369962 |
| 84 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.65273114 |
| 85 | Amoebiasis_Homo sapiens_hsa05146 | 0.65165110 |
| 86 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.64269758 |
| 87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63382543 |
| 88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.61993743 |
| 89 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.59601324 |
| 90 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.59548705 |
| 91 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.59465824 |
| 92 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.58041711 |
| 93 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57608685 |
| 94 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.56411826 |
| 95 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.56162212 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.55802036 |
| 97 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.53010023 |
| 98 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.52348799 |
| 99 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51615296 |
| 100 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.49527639 |
| 101 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.47246095 |
| 102 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.47202752 |
| 103 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45655904 |
| 104 | Thyroid cancer_Homo sapiens_hsa05216 | 0.42785751 |
| 105 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41919024 |
| 106 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.40245243 |
| 107 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.36136181 |
| 108 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.34905899 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | 0.34768573 |
| 110 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.34486577 |
| 111 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.34279502 |
| 112 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.32565030 |
| 113 | Basal transcription factors_Homo sapiens_hsa03022 | 0.31052692 |
| 114 | Galactose metabolism_Homo sapiens_hsa00052 | 0.29647760 |
| 115 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.29028049 |
| 116 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28105459 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | 0.27648778 |
| 118 | Focal adhesion_Homo sapiens_hsa04510 | 0.25188480 |
| 119 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.24875848 |
| 120 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.24378033 |
| 121 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.24297739 |
| 122 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.23817281 |
| 123 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.23009684 |
| 124 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.22778444 |
| 125 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.22011608 |

